Insiders who reported open-market trades in the last 12 months at the companies COLUMN GROUP III GP, LP files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
COLUMN GROUP III GP, LP is an investment firm of Tenaya Therapeutics, Inc. (TNYA). InsiderAlpha holds 8 primary Form 4 filings for it, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did COLUMN GROUP III GP, LP last file a Form 4?
The most recent primary Form 4 on record is dated 26 February 2026, one of 8 filings going back to 2025.
Has COLUMN GROUP III GP, LP been buying or selling stock?
Recorded transactions: 18 open-market purchases ($5.98M) and 12 open-market sales ($5.93M) across all tracked filings.
COLUMN GROUP III GP, LP files SEC Form 4 reports at Tenaya Therapeutics, Inc. (TNYA). 8 SEC Form 4 filings on record going back to 2025, most recently on 26 February 2026. Most recent open-market trade: sold $1.05M of TNYA on 26 February 2026. Lifetime open-market purchases: $5.98M. Lifetime open-market sales: $5.93M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by COLUMN GROUP III GP, LP.
InsiderAlpha's records for COLUMN GROUP III GP, LP go back to 2025: 8 primary Form 4 filings, an average of 4.0 per year. The typical open-market purchase is $332K (18 buys totaling $5.98M). The largest single buy on record is $2.12M of SRZN in 2025. Sales side: 12 recorded sales totaling $5.93M, so the filing history runs buy-heavy by dollar value. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
